This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec 1;200(11):1798-9; author reply 1799-1800.

doi: 10.1086/647991.

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus

Stefano Menzo, Donatella Vincenti, Mariacarmela Solmone, Mattia Prosperi, Alessandro Bruselles, Isabella Abbate, Gabriella Rozera, Maria Rosaria Capobianchi

PMID: 19905934
DOI: 10.1086/647991

Comment

Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus

Stefano Menzo et al. J Infect Dis. 2009.

. 2009 Dec 1;200(11):1798-9; author reply 1799-1800.

doi: 10.1086/647991.

Authors

Stefano Menzo, Donatella Vincenti, Mariacarmela Solmone, Mattia Prosperi, Alessandro Bruselles, Isabella Abbate, Gabriella Rozera, Maria Rosaria Capobianchi

PMID: 19905934
DOI: 10.1086/647991

No abstract available

PubMed Disclaimer

Comment on

Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.
Margeridon-Thermet S, Shulman NS, Ahmed A, Shahriar R, Liu T, Wang C, Holmes SP, Babrzadeh F, Gharizadeh B, Hanczaruk B, Simen BB, Egholm M, Shafer RW. Margeridon-Thermet S, et al. J Infect Dis. 2009 May 1;199(9):1275-85. doi: 10.1086/597808. J Infect Dis. 2009. PMID: 19301976 Free PMC article.

Similar articles

The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.
Gelinck LB, Claas EC, Kroon FP. Gelinck LB, et al. J Hepatol. 2005 Aug;43(2):360-1; author reply 361. doi: 10.1016/j.jhep.2005.04.005. J Hepatol. 2005. PMID: 15970350 No abstract available.
Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV.
Locarnini S, Warner N. Locarnini S, et al. Antivir Ther. 2007;12 Suppl 3:H15-23. Antivir Ther. 2007. PMID: 18284179 Review.
Cellular and virological mechanisms of HBV drug resistance.
Locarnini S, Mason WS. Locarnini S, et al. J Hepatol. 2006 Feb;44(2):422-31. doi: 10.1016/j.jhep.2005.11.036. Epub 2005 Dec 7. J Hepatol. 2006. PMID: 16364492 Review. No abstract available.
Hepatitis B virus escape mutants induced by antiviral therapy.
Sheldon J, Soriano V. Sheldon J, et al. J Antimicrob Chemother. 2008 Apr;61(4):766-8. doi: 10.1093/jac/dkn014. Epub 2008 Jan 24. J Antimicrob Chemother. 2008. PMID: 18218641 Review.
Designing a low-cost drug resistance database for viral hepatitis.
Kuiken C. Kuiken C. Antivir Ther. 2010;15(3 Pt B):517-20. doi: 10.3851/IMP1554. Antivir Ther. 2010. PMID: 20516573 Review.

See all similar articles

Cited by

Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.
Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, Kelly E, Ko HH, Ma MM, Martin SR, Osiowy C, Ramji A, Tam E, Villeneuve JP. Coffin CS, et al. Can Liver J. 2018 Dec 25;1(4):156-217. doi: 10.3138/canlivj.2018-0008. eCollection 2018 Fall. Can Liver J. 2018. PMID: 35992619 Free PMC article.
Association of preexisting drug-resistance mutations and treatment failure in hepatitis B patients.
Ma J, Zhang Y, Chen X, Jin Y, Chen D, Wu Y, Cui J, Wang H, Liu J, Li N, Gao F. Ma J, et al. PLoS One. 2013 Jul 30;8(7):e67606. doi: 10.1371/journal.pone.0067606. Print 2013. PLoS One. 2013. PMID: 23935839 Free PMC article.
Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations.
Kou R, Lam H, Duan H, Ye L, Jongkam N, Chen W, Zhang S, Li S. Kou R, et al. PLoS One. 2016 Jan 11;11(1):e0146638. doi: 10.1371/journal.pone.0146638. eCollection 2016. PLoS One. 2016. PMID: 26752634 Free PMC article.
Dynamics of mitochondrial heteroplasmy in three families investigated via a repeatable re-sequencing study.
Goto H, Dickins B, Afgan E, Paul IM, Taylor J, Makova KD, Nekrutenko A. Goto H, et al. Genome Biol. 2011;12(6):R59. doi: 10.1186/gb-2011-12-6-r59. Epub 2011 Jun 23. Genome Biol. 2011. PMID: 21699709 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems